Rational dosing of gabapentin and pregabalin in chronic kidney disease

被引：33
作者：
Raouf, Mena [1 ]
Atkinson, Timothy J. [1 ]
Crumb, Meredith W. [1 ]
Fudin, Jeffrey [2 ,3 ,4 ,5 ]
机构：
[1] VA Tennessee Valley Healthcare Syst, 3400 Lebanon Pike, Murfreesboro, TN 37129 USA
[2] Stratton VA Med Ctr, Albany, NY USA
[3] Albany Coll Pharm & Hlth Sci, Albany, NY USA
[4] Western New England Univ, Coll Pharm, Springfield, MA USA
[5] Remitigate LLC, Sci & Clin Affairs, Delmar, NY USA
来源：
JOURNAL OF PAIN RESEARCH | 2017年 / 10卷
关键词：
DOUBLE-BLIND; DIABETIC-NEUROPATHY; PHARMACOKINETICS; PAIN; PHARMACODYNAMICS; TRAFFICKING;
D O I：
10.2147/JPR.S130942
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：275 / 278
页数：4
相关论文
共 50 条
  • [31] Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy
    Yiheng Pan
    Pamela B. Davis
    David C. Kaebler
    Robert P. Blankfield
    Rong Xu
    Cardiovascular Diabetology, 21
  • [32] Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin
    Ghayur, Muhammad Nabeel
    CASE REPORTS IN MEDICINE, 2021, 2021
  • [33] Dosing of Aminoglycosides in Chronic Kidney Disease and End-Stage Renal Disease Patients Treated with Intermittent Hemodialysis
    Halouzkova, Barbora Agatha
    Hartinger, Jan Miroslav
    Kratky, Vojtech
    Tesar, Vladimir
    Slanar, Ondrej
    KIDNEY & BLOOD PRESSURE RESEARCH, 2022, 47 (07) : 448 - 458
  • [34] Does the intact nephron hypothesis provide a reasonable model for metformin dosing in chronic kidney disease?
    Pradhan, Sudeep
    Duffull, Stephen B.
    Wilson, Luke C.
    Kuan, Isabelle H. S.
    Walker, Robert J.
    Putt, Tracey L.
    Schollum, John B. W.
    Wright, Daniel F. B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (12) : 4868 - 4876
  • [35] Efficacy and Safety of Gabapentin for Uremic Pruritus and Restless Legs Syndrome in Conservatively Managed Patients With Chronic Kidney Disease
    Hassan, Hicham I. Cheikh
    Brennan, Frank
    Collett, Gemma
    Josland, Elizabeth A.
    Brown, Mark A.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 49 (04) : 782 - 789
  • [36] Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
    Matzke, Gary R.
    Aronoff, George R.
    Atkinson, Arthur J., Jr.
    Bennett, William M.
    Decker, Brian S.
    Eckardt, Kai-Uwe
    Golper, Thomas
    Grabe, Darren W.
    Kasiske, Bertram
    Keller, Frieder
    Kielstein, Jan T.
    Mehta, Ravindra
    Mueller, Bruce A.
    Pasko, Deborah A.
    Schaefer, Franz
    Sica, Domenic A.
    Inker, Lesley A.
    Umans, Jason G.
    Murray, Patrick
    KIDNEY INTERNATIONAL, 2011, 80 (11) : 1122 - 1137
  • [37] Treatment of fibromyalgia syndrome with gabapentin and pregabalin - A meta-analysis of randomized controlled trials
    Haeuser, Winfried
    Bernardy, Kathrin
    Ueceyler, Nurcan
    Sommer, Claudia
    PAIN, 2009, 145 (1-2) : 69 - 81
  • [38] Pregabalin produces similar effects as gabapentin for preanesthetic sedation in cats
    Madan, Rahul D.
    Cenani, Alessia
    Montgomery, Elizabeth
    Azevedo, Tatiana
    Vernau, Karen M.
    Brosnan, Robert J.
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2024, 262 (03): : 359 - 363
  • [39] Gabapentin or pregabalin induced myoclonus: A case series and literature review
    Desai, Aaron
    Kherallah, Yazan
    Szabo, Cheryl
    Marawar, Rohit
    JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 61 : 225 - 234
  • [40] Pain management in patients with chronic kidney disease and end-stage kidney disease
    Roy, Payel J.
    Weltman, Melanie
    Dember, Laura M.
    Liebschutz, Jane
    Jhamb, Manisha
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (06) : 671 - 680
12345